Capsulomics establishes $3.7 million NIH-funded research collaboration with Johns Hopkins University

BALTIMORE, Feb. 25, 2020 /PRNewswire/ — Capsulomics, Inc., a Baltimore-based molecular diagnostics company whose mission is to detect and prevent cancer through earlier detection, today announced a research partnership with Johns Hopkins University, funded by a 5-year, $3.7 Million NIH Academic-Industrial Partnership grant, to conduct an important clinical research study to detect esophageal cancer and its precancerous precursor condition, Barrett’s esophagus (BE).